Theralase Technologies Inc. (TSXV:TLT)
0.1800
-0.0050 (-2.70%)
Sep 22, 2026, 3:08 PM EST
Theralase Technologies Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -3.79 | -4.12 | -4.26 | -4.57 | -5.24 | -4.41 |
Depreciation & Amortization | 0.25 | 0.27 | 0.27 | 0.29 | 0.31 | 0.28 |
Stock-Based Compensation | 0.4 | 0.57 | 0.52 | 0.62 | 0.19 | 0.32 |
Other Operating Activities | -0 | - | - | 0.03 | 0.05 | 0.02 |
Change in Accounts Receivable | -0.04 | -0.45 | -0.25 | -0.03 | -0.04 | 0.18 |
Change in Inventory | 0.02 | -0.01 | 0.11 | -0.17 | 0.08 | -0.11 |
Change in Accounts Payable | -0.08 | 0.54 | 0.11 | 0.39 | -0.24 | 0.07 |
Change in Other Net Operating Assets | -0.14 | -0.08 | 0.14 | -0.63 | -0.23 | -0.38 |
Operating Cash Flow | -3.39 | -3.29 | -3.35 | -4.07 | -5.1 | -4.03 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | 0.02 | -0.05 | -0.02 | -0.04 | -0.07 | -0.1 |
Sale of Property, Plant & Equipment | 0 | - | - | - | - | - |
Investing Cash Flow | 0.03 | -0.05 | -0.02 | -0.04 | -0.07 | -0.1 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | 0.38 | - | - | - | - |
Total Debt Issued | 0.38 | 0.38 | - | - | - | - |
Long-Term Debt Repaid | - | -0.1 | -0.09 | -0.12 | -0.08 | -0.06 |
Lease Payments | -0.1 | -0.1 | -0.09 | -0.12 | -0.08 | -0.06 |
Net Debt Issued (Repaid) | 0.27 | 0.27 | -0.09 | -0.12 | -0.08 | -0.06 |
Issuance of Common Stock | 8.31 | 2.98 | 3.69 | 2.76 | 3.07 | - |
Other Financing Activities | -0 | -0 | -0 | -0 | -0 | -0 |
Financing Cash Flow | 8.58 | 3.25 | 3.6 | 2.65 | 2.99 | -0.06 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | 0 | - | - |
Net Cash Flow | 5.21 | -0.09 | 0.22 | -1.46 | -2.18 | -4.19 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -3.37 | -3.33 | -3.37 | -4.11 | -5.17 | -4.13 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -419.76% | -408.43% | -326.11% | -384.01% | -454.37% | -529.21% |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 | -0.02 |
Levered Free Cash Flow | -2.23 | -2 | -1.88 | -2.09 | -2.78 | -2.54 |
Unlevered Free Cash Flow | -2.19 | -1.97 | -1.87 | -2.07 | -2.77 | -2.54 |
Free Cash Flow After Leases | -3.47 | -3.43 | -3.46 | -4.23 | -5.25 | -4.19 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.04 | 0.02 | - | - | - | - |
Change in Working Capital | -0.24 | -0.01 | 0.11 | -0.44 | -0.42 | -0.24 |